Class information for:
Level 1: MESALAZINE//5 AMINOSALICYLIC ACID//MESALAMINE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
5137 1598 39.6 69%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
88 25697 ULCERATIVE COLITIS//CROHNS DISEASE//INFLAMMATORY BOWEL DISEASE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 MESALAZINE Author keyword 59 41% 7% 114
2 5 AMINOSALICYLIC ACID Author keyword 42 33% 7% 106
3 MESALAMINE Author keyword 41 40% 5% 80
4 AMINOSALICYLATES Author keyword 21 51% 2% 30
5 5 AMINOSALICYCLIC ACID Author keyword 15 68% 1% 13
6 OLSALAZINE Author keyword 14 50% 1% 20
7 5 ASA Author keyword 14 31% 2% 37
8 DISTAL ULCERATIVE COLITIS Author keyword 10 73% 1% 8
9 5 AMINOSALICYLATE Author keyword 10 44% 1% 17
10 ULCERATIVE PROCTITIS Author keyword 8 44% 1% 14

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 MESALAZINE 59 41% 7% 114 Search MESALAZINE Search MESALAZINE
2 5 AMINOSALICYLIC ACID 42 33% 7% 106 Search 5+AMINOSALICYLIC+ACID Search 5+AMINOSALICYLIC+ACID
3 MESALAMINE 41 40% 5% 80 Search MESALAMINE Search MESALAMINE
4 AMINOSALICYLATES 21 51% 2% 30 Search AMINOSALICYLATES Search AMINOSALICYLATES
5 5 AMINOSALICYCLIC ACID 15 68% 1% 13 Search 5+AMINOSALICYCLIC+ACID Search 5+AMINOSALICYCLIC+ACID
6 OLSALAZINE 14 50% 1% 20 Search OLSALAZINE Search OLSALAZINE
7 5 ASA 14 31% 2% 37 Search 5+ASA Search 5+ASA
8 DISTAL ULCERATIVE COLITIS 10 73% 1% 8 Search DISTAL+ULCERATIVE+COLITIS Search DISTAL+ULCERATIVE+COLITIS
9 5 AMINOSALICYLATE 10 44% 1% 17 Search 5+AMINOSALICYLATE Search 5+AMINOSALICYLATE
10 ULCERATIVE PROCTITIS 8 44% 1% 14 Search ULCERATIVE+PROCTITIS Search ULCERATIVE+PROCTITIS

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 5 AMINOSALICYLIC ACID 118 30% 21% 330
2 5 AMINOSALICYLIC ACID ENEMAS 84 70% 4% 69
3 MESALAZINE 71 37% 10% 154
4 DELAYED RELEASE MESALAZINE 41 90% 1% 18
5 MMX MESALAMINE 41 65% 3% 40
6 MODIFIED RELEASE BUDESONIDE 39 74% 2% 29
7 MESALAMINE 39 31% 7% 104
8 SULFASALAZINE 38 17% 13% 208
9 DISODIUM AZODISALICYLATE 37 100% 1% 14
10 5 ASA 36 69% 2% 31

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Review article: integrating budesonide-MMX into treatment algorithms for mild-to-moderate ulcerative colitis 2014 7 46 76%
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee 2010 305 373 21%
European evidence-based Consensus on the management of ulcerative colitis: Current management 2008 270 294 28%
Ulcerative colitis practice guidelines in adults (update): American College of Gastroenterology, Practice Parameters Committee 2004 322 148 34%
Oral 5-aminosalicylic acid for maintenance of remission in ulcerative colitis 2006 80 54 87%
Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis 2011 41 44 77%
Are There Any Differences in the Efficacy and Safety of Different Formulations of Oral 5-ASA Used for Induction and Maintenance of Remission in Ulcerative Colitis? Evidence from Cochrane Reviews 2013 9 35 94%
Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis 2006 71 59 88%
A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis 2000 130 68 87%
Systematic review: short-term adverse effects of 5-aminosalicylic acid agents in the treatment of ulcerative colitis 2004 83 51 94%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 DIGEST DIS EXCELLENCE 4 75% 0.2% 3
2 NASHVILLE MED 3 60% 0.2% 3
3 CLIN IBD 2 67% 0.1% 2
4 MARIA NATHANSON 2 67% 0.1% 2
5 EVANGEL KRANKENHAUS KALK 2 31% 0.3% 5
6 LATVIAN GASTROENTEROL 1 100% 0.1% 2
7 SECT GASTROENTEROL NUTR 1 12% 0.6% 9
8 DIGEST ENDOSCOPY GASTROENTEROL 1 40% 0.1% 2
9 INFLAMMATORY BOWEL DIS GASTROENTEROL 1 27% 0.2% 3
10 INFUS 1 25% 0.2% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000282366 SEVERE ULCERATIVE COLITIS//TOXIC MEGACOLON//STEROID REFRACTORY ULCERATIVE COLITIS
2 0.0000161986 SULFASALAZINE//SULPHASALAZINE//2ND LINE AGENT
3 0.0000155581 INFLIXIMAB//VEDOLIZUMAB//ADALIMUMAB
4 0.0000136025 ADHERENT INVASIVE E COLI//ADHERENT INVASIVE ESCHERICHIA COLI//JE2526
5 0.0000124353 ACETIC ACID INDUCED COLITIS//EXPERIMENTAL COLITIS//COLONIC PERFUSION
6 0.0000116064 FECAL CALPROTECTIN//CALPROTECTIN//FECAL ALPHA 1 ANTITRYPSIN
7 0.0000114418 COLON SPECIFIC DRUG DELIVERY//COLONIC DELIVERY//COLON TARGETING
8 0.0000113341 INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE//UBERT MARTIN INFLAMMATORY BOWEL DIS//UNITAT ATENCIO CROHN COLITIS
9 0.0000094490 LEUKOCYTAPHERESIS//ADACOLUMN//GRANULOCYTE AND MONOCYTE ADSORPTION APHERESIS
10 0.0000091358 EXTRAINTESTINAL MANIFESTATIONS//EXTRAINTESTINAL MANIFESTATION//LUNG BEING CONNECTED WITH LARGE INTESTINE